Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
Calgary man dies after contracting COVID-19 at Foothills hospital;family seeks remdesivir for daughter on ventilator.
A Calgary family is mourning the death of their father after he was diagnosed with COVID-19 while being treated at the Foothills hospital. The family is fighting for his daughter, who also tested positive, to have access to remdesivir.
Here's a look at what we know and what we don't know so far.